Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades

CONCLUSION: Both glargine formulations are largely comparable to other basal insulins in terms of glucose-lowering properties in T1DM. Further, risk of hypoglycemia is lower with Gla-100 than Neutral Protamine Hagedorn but comparable to insulin detemir.PMID:36896906 | DOI:10.2174/1573399819666230310150905

Source: Current Diabetes Reviews - March 10, 2023 Category: Endocrinology Authors: Banshi Saboo Hemraj Chandalia Sujoy Ghosh Jothydev Kesavadev Ips Kochar K M Prasannakumar Archana Sarda Ganapathi Bantwal R N Mehrotra Madhukar Rai Source Type: research